本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akari Therapeutics PLC

1.13
-0.0143-1.25%
盘后1.130.00000.00%16:15 EDT
成交量:1.69万
成交额:1.92万
市值:3,638.18万
市盈率:-0.68
高:1.15
开:1.14
低:1.11
收:1.15
数据加载中...
2022/01/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/30

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/21

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/30

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/16

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/24

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/17

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/07/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/04/15

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]